Inventor
GAMBOA JUAN ANTONIO
US9 patents
⚠️ This page may combine multiple inventors who share the name “GAMBOA JUAN ANTONIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNAL PHARM LLC
6 patentsUS9079900B2Jul 14, 2015
Methods of synthesis and purification of heteroaryl compounds
SIGNAL PHARM LLC5 citations82
US9403829B2Aug 2, 2016
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use
SIGNAL PHARM LLC13 citations81
US8686135B2Apr 1, 2014
Methods of synthesis and purification of heteroaryl compounds
SIGNAL PHARM LLC8 citations81
US9604939B2Mar 28, 2017
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use
SIGNAL PHARM LLC1 citations59
US9974786B2May 22, 2018
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use
SIGNAL PHARM LLC0 citations48
US9795603B2Oct 24, 2017
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use
SIGNAL PHARM LLC0 citations48
AVENTIS PHARMA INC
2 patentsUS7402672B2Jul 22, 2008
Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
AVENTIS PHARMA INC6 citations69
US7626027B2Dec 1, 2009
Substituted 1H-pyrrolo[2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase Iε
AVENTIS PHARMA INC0 citations47